So, Ceritinib is a thing that stops ALK from working, and it’s given to people with a kind of lung cancer called ALK-positive metastatic non-small cell lung cancer (NSCLC). It comes as 150 mg caps. You’re supposed to take 450 mg of it, every day with a meal.
Each bottle of it holds 70 pills. The big deal here with Ceritinib is it goes after something called the ALK signaling pathway. That pathway is key in the whole shebang, you know, causing that cancer thingy to grow and spread in folks with this ALK-positive cancer.
Reviews
There are no reviews yet.